159.66
전일 마감가:
$160.12
열려 있는:
$161.84
하루 거래량:
1.11M
Relative Volume:
0.46
시가총액:
$33.75B
수익:
$398.11M
순이익/손실:
$-1.03B
주가수익비율:
-27.99
EPS:
-5.7032
순현금흐름:
$-868.57M
1주 성능:
-3.68%
1개월 성능:
+13.23%
6개월 성능:
+131.53%
1년 성능:
+122.65%
Insmed Inc Stock (INSM) Company Profile
명칭
Insmed Inc
전화
908-977-9900
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
INSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
INSM
Insmed Inc
|
159.66 | 33.85B | 398.11M | -1.03B | -868.57M | -5.7032 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-08-20 | 개시 | William Blair | Outperform |
| 2025-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 개시 | Jefferies | Buy |
| 2025-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-23 | 개시 | Truist | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-07-26 | 개시 | Guggenheim | Buy |
| 2022-12-09 | 개시 | Mizuho | Buy |
| 2022-12-07 | 개시 | Barclays | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Buy |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2021-12-06 | 개시 | JP Morgan | Overweight |
| 2021-10-19 | 재개 | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 재개 | Morgan Stanley | Overweight |
| 2021-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-10-12 | 재개 | Stifel | Buy |
| 2019-09-03 | 개시 | Goldman | Buy |
| 2019-04-09 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-15 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-01-02 | 개시 | Canaccord Genuity | Buy |
| 2018-08-06 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 개시 | Goldman | Neutral |
| 2018-04-23 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 개시 | Morgan Stanley | Overweight |
| 2018-01-18 | 개시 | Credit Suisse | Neutral |
| 2017-09-05 | 재확인 | Evercore ISI | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-11 | 개시 | Robert W. Baird | Outperform |
| 2016-03-15 | 개시 | Stifel | Buy |
| 2015-11-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2015-10-06 | 재확인 | H.C. Wainwright | Buy |
| 2015-06-09 | 개시 | Citigroup | Neutral |
| 2014-03-26 | 재확인 | HC Wainwright | Buy |
모두보기
Insmed Inc 주식(INSM)의 최신 뉴스
Insmed Incorporated stock volume spike explainedOptions Play & Real-Time Volume Trigger Notifications - newser.com
Is Insmed Incorporated (IM8N) stock among top earnings playsPortfolio Profit Report & High Conviction Buy Zone Alerts - newser.com
What dividend safety score for Insmed Incorporated stockWeekly Risk Summary & Free Real-Time Market Sentiment Alerts - newser.com
Will Insmed Incorporated stock outperform Dow Jones indexQuarterly Risk Review & Weekly Market Pulse Alerts - newser.com
What machine learning models say about Insmed Incorporated2025 Major Catalysts & Technical Entry and Exit Tips - newser.com
What indicators show strength in Insmed IncorporatedQuarterly Growth Report & Verified Short-Term Trading Plans - newser.com
Is a relief rally coming for Insmed Incorporated holdersTrade Performance Summary & Verified Momentum Stock Alerts - newser.com
How Insmed Incorporated (IM8N) stock performs during market turbulenceWeekly Gains Summary & Consistent Profit Focused Trading Strategies - newser.com
Will Insmed Incorporated (IM8N) stock see valuation expansion2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
How Insmed Incorporated stock reacts to Fed rate cuts2025 Buyback Activity & Daily Profit Maximizing Trade Tips - newser.com
Insmed (Nasdaq: INSM) named No. 1 biopharma employer by Science for fifth straight year - Stock Titan
Analysts Estimate Insmed (INSM) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Why Insmed Incorporated (IM8N) stock is listed among top recommendationsSell Signal & Verified Short-Term Trading Plans - newser.com
Reversal indicators forming on Insmed Incorporated stockEntry Point & High Conviction Trade Alerts - newser.com
Key metrics from Insmed Incorporated’s quarterly dataLayoff News & Reliable Breakout Forecasts - newser.com
Insmed Incorporated stock prediction for this week2025 Risk Factors & Low Drawdown Momentum Ideas - newser.com
Volatility clustering patterns for Insmed IncorporatedLayoff News & Free Weekly Chart Analysis and Trade Guides - newser.com
Insmed Inc stock reaches 52-week high at 167.0 USD - Investing.com India
Insmed Inc stock reaches 52-week high at 167.0 USD By Investing.com - Investing.com Nigeria
How to build a custom watchlist for Insmed IncorporatedMarket Performance Report & Free Expert Approved Momentum Trade Ideas - newser.com
Insmed Inc (INSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):